Full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: results of a prospective study in nonrandomized and unselected population of 396 patient

• Authors: SKŘIČKOVÁ Jana; KADLEC Bohdan; VENCLÍČEK Ondřej; JAKUBÍKOVÁ Lenka; JANÁSKOVÁ Tereza; KOLEK Vítězslav; GRYGÁRKOVÁ Ivona; ČOUPKOVÁ Helena; CHALUPA Jiří; BARTOŠ Jiří; REITERER Pavel; ZEMANOVÁ Milada
• Year of publication: 2013
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: In this group of 396 unselected patients with advanced NSCLC was the treatment with full NVBO and-CBDCA in first line more convenient and well tolerated with evidence of high antitumour activity. This combination was active in all groups patients according histology (mOS was 9,92 and mPFS was 7,4 months). Statistically significant better were the results in patients with PS 0+1.